title: Addressing cost-containment and cost-effectiveness in magnetic resonance contrast agent development.
authors.affiliation: Squibb Diagnostics, Princeton, New Jersey 08543-4500.
authors.forename: R A
authors.initials: RA
authors.lastname: Ashley
authors.forename: M J
authors.initials: MJ
authors.lastname: Carvlin
authors.forename: T P
authors.initials: TP
authors.lastname: Lucas
authors.forename: A Y
authors.initials: AY
authors.lastname: Olukotun
mesh_terms: D001932:Brain Neoplasms / Q000175:diagnosis / Q000556:secondary; D003287:Contrast Media / Q000191:economics*; D003363:Cost Control; D003362:Cost-Benefit Analysis; D005682:Gadolinium; D006571:Heterocyclic Compounds; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000191:economics*; D009942:Organometallic Compounds; D014481:United States
chemical_list: D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; D005682:Gadolinium